ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ENSG vs EHC // FORWARD P/E MULTIPLE

The Ensign Group Inc. (NASDAQ) VS. Encompass Health Corporation (NYSE) • 15-METRIC TALLY: ENSG 4 — EHC 9
▲ FORWARD P/E MULTIPLE LEADER: EHC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. EHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ENSG EHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 20.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 18.00% 13.80% +4.20 ENSG /roic <GO>
EV/EBITDA & P/E Valuation 17.0x 15.8x +1.20 EHC /valuation <GO>
Free Cash Flow Yield 3.11% 2.92% +0.19 ENSG /fcf-yield <GO>
Operating Margin 8.50% 11.60% -3.10 EHC /operating-margins <GO>
Net Profit Margin 6.80% 9.50% -2.70 EHC /net-margins <GO>
Revenue Growth (YoY) 18.80% 10.50% +8.30 ENSG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.13% 0.55% -0.42 EHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.73 3.47 +0.26 ENSG /balance-sheet <GO>
Piotroski F-Score Quality 8/9 9/9 -1.00 EHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.1 65.5 -11.40 EHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.89 0.90 -0.01 EHC /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 26.5x 21.3x +5.20 EHC /forward-pe <GO>
Enterprise Scale & Market Cap $10.59B $13.41B -$2.82B EHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ENSG REV EHC REV ENSG GROSS % EHC GROSS % ENSG FCF EHC FCF
FY 2025 $5.03B $5.94B 20.1% — $337.8M —
FY 2024 $4.24B $5.37B 20.3% — $156.5M —
FY 2023 $3.71B $4.80B — — $209.8M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
EHC // BETA 0.90